Skip to main content

Table 1 Chemoresistance model that modulates CS-GRP78 expression

From: Cell surface GRP78: a potential mechanism of therapeutic resistant tumors

Chemotherapy drugs

Resistance model

Reference

Gemcitabine

Doxorubicin

Paclitaxel

Cisplatin

Bortezomib

Rapamycin

5-Flurouracil

Pancreatic cancer

Breast cancer

Prostate cancer

Lung cancer

Prostate Cancer

Prostate Cancer

Hepatocellular Carcinoma

[42]

[43]

[41]

[20]

[77]

[113]

[80]